SIM
VYGR icon

Spark Investment Management’s Voyager Therapeutics VYGR Stock Holding History

Spark Investment Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-146,200
Closed -$2.8M – 711
2019
Q1 		$2.8M Buy
146,200
+22,800
+18% +$297K 0.13% 203
2018
Q4 		$1.16M Buy
+123,400
New +$1.58M 0.08% 292

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Spark Investment Management's VYGR Position: Q2 2019 in Review

Spark Investment Management sold out of Voyager Therapeutics (VYGR) in Q2 2019, closing a stake of 146,200 shares — an estimated $2.8M sold.

Spark Investment Management first reported a position in VYGR in Q4 2018 and held it in 2 quarters. The position peaked at $2.8M in Q1 2019. 125 funds tracked by Wall St. Rank hold VYGR as of Q2 2019.

  • Spark Investment Management reported no remaining Voyager Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Spark Investment Management sold 146,200 Voyager Therapeutics shares in Q2 2019, an estimated $2.8M.
  • Spark Investment Management first reported a position in Voyager Therapeutics in Q4 2018 and held it in 2 quarters.
  • Spark Investment Management's Voyager Therapeutics position peaked at $2.8M in Q1 2019.
  • 125 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2019.

Based on Spark Investment Management's 13F filing for Q2 2019, filed 12 Aug 2019.